first reported two CD7 CAR-NK92-MI cell constructs using the CD7 nanobody VHH6 sequences; they demonstrated that CD7 CAR-NK92-MI cells exert specific cytotoxicity and an inhibitory effect on primary T-ALL cells in a PDX mouse model (98). The gene discussed is CD7; the disease is acute lymphoblastic leukemia.